28 May 2008 - 14:17FDA Approval Of Wyeth Menopause Treatment Pristiq Delayed

Wyeth by Thursday said that regulatory permission of its alien medication, Pristiq, a nonhormonal remedy in like better of sultry flash and other menopause symptom, be delayed until at finest minuscule July to distribute FDA event to scrutiny new background on the drug, the AP/Forbes reports. FDA be awake to resolve whether to contract Pristiq subsequent week. The drug is a new text of Wyeth’s decline treatment Effexor, which will misplace rights rasping contained by routine of 2010. According to the AP/Forbes, Wyeth is seeking approval from FDA to souk Pristiq by the use of a depression treatment for elder women, as resourcefully as a treatment for menopause symptoms. FDA’s review of the drug as a depression treatment also will be delayed (Perrone, AP/Forbes, 4/19). Company laypeople servant in a convention call for in the vicinity analysts on Thursday said that they be sending FDA data showing rate but superior tolerability for a degrade dose, 50-milligram dose of Pristiq, Reuters reports. The guests wait for that Pristiq will be agreed to excess hot flashes in the third quarter of 2007 but that approval to treat depression will not come until the preliminary quarter of 2008 (Reuters, 4/19).

As once announced by May 17, 2006, once-daily AZILECT(R) received compliments from the U.S. Food and Drug Administration (FDA) by means of a psychotherapy for Parkinson’s disease both as first monotherapy in precipitate Parkinson’s disease patients and as adjunct psychiatric give a hand to levodopa in moderate-to-advanced chapter of the disease. AZILECT(R) will be at your disposal in the U.S. with the end of this month.

symptom genital herpes for herpes treatment on buyzoviraxonline.com store!